About this trial
This study will be conducted to compare the effect of Erythropoietin gel mixed with xenograft versus xenograft alone in grafting the jumping gap around immediate implant.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Both genders aged from 20 to 50 years.
Systemically free patients as evidenced by Burket's oral health history questionnaire.
Patients need the extraction of non-restorable maxillary tooth in esthetic zone and the possibility of immediate placement of implants on the same site with Intact labial plate and interproximal bone levels (socket type 1).
Gap space of more than 2 mm between the implant and buccal bone.
Disqualifiers
Smokers.
Pregnant or lactating females.
Acute infection at the implant site
Patients under any medication that affects the healing.
Trial design
Parallel
Treatments tested in this trial
Erythropoetin gel mixed with xenogenic bone graft
DrugPatients with EPO gel mixed with xenogenic bone graft in the jumping gap of immediate implant.
Xenogenic bone with gelling aget CMC ( carboxymethyl cellulose)
Other interventionPatients with xenogenic bone graft and gelling agent in the jumping gap of immediate implant.
Treatment groups
Trial outcomes
Primary outcomes
Radiographic assessment
Radiographic assessment of alveolar bone width by CBCT
Secondary outcomes
Radiographic assessment
Radiographic assessment of alveolar bone height by CBCT
Clinical assessment
Clinical assessment (Soft tissue height and thickness)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: